BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tabak YP, Srinivasan A, Yu KC, Kurtz SG, Gupta V, Gelone S, Scoble PJ, McDonald LC. Hospital-level high-risk antibiotic use in relation to hospital-associated Clostridioides difficile infections: Retrospective analysis of 2016-2017 data from US hospitals. Infect Control Hosp Epidemiol 2019;40:1229-35. [PMID: 31522695 DOI: 10.1017/ice.2019.236] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Krah NM, Jones TW, Lake J, Hersh AL. The impact of antibiotic allergy labels on antibiotic exposure, clinical outcomes, and healthcare costs: A systematic review. Infect Control Hosp Epidemiol 2021;42:530-48. [PMID: 33059777 DOI: 10.1017/ice.2020.1229] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Puzniak L, Finelli L, Yu KC, Bauer KA, Moise P, De Anda C, Vankeepuram L, Sepassi A, Gupta V. A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19. BMC Infect Dis 2021;21:227. [PMID: 33639862 DOI: 10.1186/s12879-021-05877-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kruger Howard A, Parbuoni KA, Claeys K, Biggs JM, Seung H, Johnson K, Campbell J, Morgan JA. Validation of neonatal and paediatric antimicrobial stewardship treatment algorithms in rapid diagnostic-detected bacteraemia. Int J Pharm Pract 2021:riab031. [PMID: 34173658 DOI: 10.1093/ijpp/riab031] [Reference Citation Analysis]
4 Puzniak L, Bauer KA, Yu KC, Moise P, Finelli L, Ye G, De Anda C, Vankeepuram L, Gupta V. Effect of Inadequate Empiric Antibacterial Therapy on Hospital Outcomes in SARS-CoV-2-Positive and -Negative US Patients With a Positive Bacterial Culture: A Multicenter Evaluation From March to November 2020. Open Forum Infect Dis 2021;8:ofab232. [PMID: 34141818 DOI: 10.1093/ofid/ofab232] [Reference Citation Analysis]
5 García-Rodríguez JF, Bardán-García B, Juiz-González PM, Vilariño-Maneiro L, Álvarez-Díaz H, Mariño-Callejo A. Long-Term Carbapenems Antimicrobial Stewardship Program. Antibiotics (Basel) 2020;10:15. [PMID: 33375237 DOI: 10.3390/antibiotics10010015] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Cowman K, Chen V, Guo Y, Nori P. Using Technology to Enhance Antimicrobial Stewardship Impact in the Acute Care Setting. Curr Treat Options Infect Dis 2020;12:145-57. [DOI: 10.1007/s40506-020-00218-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
7 Wombwell E, Patterson ME, Bransteitter B, Gillen LR. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection. Clinical Infectious Diseases 2020. [DOI: 10.1093/cid/ciaa808] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Gupta V, Yu KC, Schranz J, Gelone SP. A Multicenter Evaluation of the US Prevalence and Regional Variation in Macrolide-Resistant S. pneumoniae in Ambulatory and Hospitalized Adult Patients in the United States. Open Forum Infect Dis 2021;8:ofab063. [PMID: 34250183 DOI: 10.1093/ofid/ofab063] [Reference Citation Analysis]
9 Goodman KE, Cosgrove SE, Pineles L, Magder LS, Anderson DJ, Dodds Ashley E, Polk RE, Quan H, Trick WE, Woeltje KF, Leekha S, Harris AD. Significant Regional Differences in Antibiotic Use Across 576 US Hospitals and 11 701 326 Adult Admissions, 2016-2017. Clin Infect Dis 2021;73:213-22. [PMID: 32421195 DOI: 10.1093/cid/ciaa570] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
10 Yu KC, Yamaga C, Vankeepuram L, Tabak YP. Relationships between creatinine increase and mortality rates in patients given vancomycin in 76 hospitals: The increasing role of infectious disease pharmacists. Am J Health Syst Pharm 2021:zxab247. [PMID: 34125896 DOI: 10.1093/ajhp/zxab247] [Reference Citation Analysis]
11 O'Donnell JN, Novak GM, Bratek BR, Singh G, Duru OO, Mitchell CL, Roddy KM, Bidell MR. Effect of oral vancomycin dose on outcomes in patients with Clostridioides difficile infection. Int J Antimicrob Agents 2021;57:106311. [PMID: 33621602 DOI: 10.1016/j.ijantimicag.2021.106311] [Reference Citation Analysis]